FindTrial
Sign In

Outcomes of Renal Replacement Therapy requiring CKD5 Elderly Patients

Outcomes Of Renal Replacement Therapy Requiring CKD-5 Geriatric Population - ORTGP

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/07/034511
Enrollment
118
Registered
2021-07-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N185- Chronic kidney disease, stage 5

Interventions

None listed

Sponsors

ABVIMS and DR RML HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) age > 60 years 2 >CKD-5 Patients

Exclusion criteria

Exclusion criteria: 1)CKD-5 Patients not willing to participate in study 2)Patients suffering from terminal non renal related illness 3)Patients with active infection at enrollment 4)Patients with dementia or neuropsychiatric illness

Design outcomes

Primary

MeasureTime frame
To study the mortality in CKD5 Renal replacement therapy requiring geriatric population.Timepoint: baseline,3 months and 6 months—

Secondary

MeasureTime frame
to study the morbidityTimepoint: baseline,3 months and 6 months—

Countries

India

Contacts

Public ContactSanket Kishor Patil

ABVIMS AND DR RML HOSPITAL

drlalitkpursnani@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026